Alterity Therapeutics (ADR) (ATHE)
Develops ATH434, a clinical candidate for multiple system atrophy and related Parkinsonian disorders.
$4.55
At close0.00 (0.00%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Feb '24Apr '24Aug '24Feb '25Feb '25Aug '25Feb '26Aug '26
Reported$0.00$0.00$0.00$0.00$0.00−$0.40−$0.38−$0.05
Estimate−$0.11—−$0.05—−$0.53−$0.43−$0.23−$0.12
Surprise+97.5%—+96.2%—+99.9%+7.2%−65.9%+56.0%
RevenueReportedEstimate
Feb '24Apr '24Aug '24Feb '25Feb '25Aug '25Feb '26Aug '26
Reported$1.9M$1.1M$2.1M$803.0K$803.0K$3.8M$645.9K$289.0K
Estimate$958.3K—$950.0K—$2.3M$5.1M$1.1M$2.3M
Surprise+98.4%—+123.0%—−65.1%−24.1%−39.6%−87.5%
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.12 | −$0.05 | +56.0% |
| Feb 2026 | −$0.23 | −$0.38 | −65.9% |
| Aug 2025 | −$0.43 | −$0.40 | +7.2% |
| Aug 2025 | — | — | — |
| Feb 2025 | −$0.53 | $0.00 | +99.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Feb 2025 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Jan 2024 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Feb 2022 | |||
| Dec 2021 | |||
| Aug 2021 | −$1.43 | — | — |
| Jun 2021 | |||
| Feb 2021 | — | — | — |
| Dec 2020 | |||
| Aug 2020 | — | — | — |
| Jun 2020 | |||
| Feb 2020 | — | — | — |
| Dec 2019 | |||
| Aug 2019 | −$2.31 | — | — |
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Dec 2014 | |||
| Jun 2014 | |||
| Dec 2013 | |||
| Jun 2013 | |||
| Dec 2012 | |||
| Jun 2012 | |||
| Dec 2011 | |||
| Jun 2011 | |||
| Dec 2010 | |||
| Jun 2010 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | −$0.12 | −$0.05 | +56.0% | $2.3M | $289.0K | −87.5% | −1.1% |
| Feb 25, 2026 | −$0.23 | −$0.38 | −65.9% | $1.1M | $645.9K | −39.6% | +2.9% |
| Aug 28, 2025 | −$0.43 | −$0.40 | +7.2% | $5.1M | $3.8M | −24.1% | −1.6% |
| Aug 4, 2025 | — | — | — | — | — | — | — |
| Feb 28, 2025 | −$0.53 | $0.00 | +99.9% | $2.3M | $803.0K | −65.1% | −3.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Feb 3, 2025 | |||||||
| Aug 29, 2024 | |||||||
| Apr 11, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Jan 30, 2024 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Aug 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Aug 31, 2021 | −$1.43 | — | — | $1.4M | — | — | — |
| Jun 30, 2021 | |||||||
| Feb 25, 2021 | — | — | — | — | — | — | — |
| Dec 31, 2020 | |||||||
| Aug 31, 2020 | — | — | — | — | — | — | — |
| Jun 30, 2020 | |||||||
| Feb 27, 2020 | — | — | — | — | — | — | — |
| Dec 31, 2019 | |||||||
| Aug 30, 2019 | −$2.31 | — | — | $1.0M | — | — | — |
| Jun 30, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Jun 30, 2013 | |||||||
| Dec 31, 2012 | |||||||
| Jun 30, 2012 | |||||||
| Dec 30, 2011 | |||||||
| Jun 30, 2011 | |||||||
| Dec 30, 2010 | |||||||
| Jun 30, 2010 | |||||||